Ezetimibe + other lipid-lowering medication(s)

DRUG2 trials

Sponsors

Organon and Co

Conditions

Familial HypercholesterolemiaHomozygous SitosterolemiaHypercholesterolemia

Unknown Phase

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

CompletedNCT00704444

Organon and CoFamilial Hypercholesterolemia, Homozygous Sitosterolemia, Hypercholesterolemia

Start: 2007-06-30End: 2009-09-30Updated: 2022-02-16

A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

CompletedNCT00705211

Organon and CoFamilial Hypercholesterolemia, Homozygous Sitosterolemia, Hypercholesterolemia

Start: 2007-06-30End: 2009-12-31Updated: 2022-02-16